Skip to content

Transactions

Sichenzia Ross Ference Kesner LLP Represents ToughBuilt Industries, Inc. in $6.1 Million Private Offering

May 6, 2020

Sichenzia Ross Ference Kesner LLP Represents ABT Holdings, Inc. in $5 Million Private Offering of Senior Secured Convertible Debentures

May 6, 2020

Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for a $3 Million Private Placement

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Network 1 Securities in $7.7 Million IPO and NASDAQ listing of ShineCo, Inc.

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents BioPharmX Corporation in $930,000 Registered Direct Offering

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents General Cannabis Corp. in $2.6 million Private Offering of Senior Secured Notes and Warrants

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents SITO MOBILE, Ltd. in $11.5 Million Public Offering

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $5 Million Registered Direct Offering

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Aridis Pharmaceuticals in $15 Million Private Placement

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $3.77 Registered Direct Offering

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Vuzix Corporation in $6.6 Million Public Offering

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Joseph Gunnar in $2.1 Million Public Offering of Intellicheck Mobilisa, Inc.

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Axiom Capital Management, Inc. In $1.2 Million Public Offering of iSign Solutions Inc.

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Joseph Gunnar and Fordham Financial Management in $7.5 Million Public Offering of Aytu Bioscience, Inc.

May 6, 2020

Partner Jeffrey Fessler Represents Synergy Pharmaceuticals Inc. on $89.8 Million Registered Direct Offering of Common Stock

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents DelMar Pharmaceuticals, Inc. in $7.5 Million Sale of Series B Preferred Shares

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Citius Pharmaceuticals Inc. in connection with its acquisition of LM Biosciences, Inc.

May 6, 2020

Partner Jeffrey Fessler Represents ContraVir Pharmaceuticals, Inc. on $7.0 Million Public Offering of Common Stock and Warrants

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents H.C. Wainwright & Co., LLC and Joseph Gunnar & Co., LLC as Joint Book Running Managers for $6.0 Public Offering and Uplisting to Nasdaq

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Viatar CTC Solutions Inc. in a $4.2 Million Private Placement

May 6, 2020

Sichenzia Ross Friedman Ference LLP Represents Laidlaw & Company (UK) Ltd. as Placement Agent for a $6.9 Million Private Placement

May 6, 2020